MyFinsight
Home
Blog
About
Contact
Download
Download image
Gross
margin-Reportable Segment
$366,081K
Cost of goods sold
$23,049K
Product revenue, net
$389,130K
Income (loss) from
operations
$161,295K
Interest and other
income, net
$28,176K
Total operating
expenses
$227,835K
Income before income
taxes
$189,471K
Income tax benefit
(expense)
-$15,360K
Selling, general and
administrative
$146,741K
Research and development
$58,045K
Cost of goods sold
$23,049K
Net income
$204,831K
Foreign currency
translation
$684K
Unrealized gain (loss) on
available-for-sale securities, net...
$642K
Comprehensive income
$206,157K
Back
Back
Income Statement
source: myfinsight.com
Krystal Biotech, Inc. (KRYS)
Krystal Biotech, Inc. (KRYS)